CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- 4 Open-market sale Chief Executive Officer sold 8,831 shares at an average $23.89 ($211,005)
- 4 Open-market sale Chief Operating Officer sold 8,831 shares at an average $23.89 ($211,005)
- 4 Open-market sale President sold 4,857 shares at an average $23.89 ($116,051)
- 4 Open-market sale Chief Medical Officer sold 7,065 shares at an average $23.89 ($168,809)
- 4 Open-market sale Chief Operating Officer sold 1,044 shares at $24.91 ($26,006)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Grant or award Director acquired 3,000 shares (grant or award)
- 4 Open-market buy Director bought 4,133 shares at $31.37 ($129,652)
- 4 Open-market sale Chief Medical Officer sold 4,133 shares at $31.37 ($129,652)
- 4 Open-market buy Director bought 20,000 shares at $28.35 ($566,996)
- 4 Open-market sale Chief Medical Officer sold 2,127 shares at $35.03 ($74,509)
- 4 Open-market sale Chief Operating Officer sold 8,661 shares at $35.03 ($303,394)
- 4 Gift Chief Executive Officer gave 311,900 shares (gift)
- 4 Open-market buy 10% owner bought 5,650,000 shares at $39.00 ($220,350,000)
- 4 Grant or award General Counsel acquired 12,538 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 45,000 shares (grant or award)
Page 10 of 15 · 290 filings